Related Experiment Videos
Updating the approach to Crohn's disease
1Section of Gastroenterology, University of Chicago Medical Center, USA.
Hospital Practice (1995)
|August 25, 1999
Abstract:
Recognizing clinical and pathologic scenarios, rather than ordering definitive tests, is still the basis for diagnosis of Crohn's disease. Steroids, salicylates, immunomodulating agents, and surgery remain the focus of treatment. The advent of infliximab, however, offers a new therapeutic option for patients with refractory disease.